Literature DB >> 22057582

Risk factor profiles based on estimated glomerular filtration rate and dipstick proteinuria among participants of the Specific Health Check and Guidance System in Japan 2008.

Kunitoshi Iseki1, Koichi Asahi, Toshiki Moriyama, Kunihiro Yamagata, Kazuhiko Tsuruya, Hideaki Yoshida, Shoichi Fujimoto, Tsuneo Konta, Issei Kurahashi, Yasuo Ohashi, Tsuyoshi Watanabe.   

Abstract

BACKGROUND: Estimated glomerular filtration rate (eGFR) and albuminuria (proteinuria) are both important determinants of the risk of cardiovascular disease (CVD), end-stage renal disease (ESRD), and mortality. Few studies, however, have examined the risk factor profiles based on eGFR and proteinuria among the general population.
METHODS: Data of the newly developed nationwide screening program of the Specific Health Check-up and Guidance System (Tokutei-Kensin) initiated in 2008 were used in this study. The aim of this screening, targeting people 40-74 years of age, was to detect those with metabolic syndrome and to offer those services regarding lifestyle modifications that will lead to the reduction of diabetes mellitus (DM) and DM-related ESRD. Individual records of 580,000 participants in 69 cities and towns and 3 union cohorts throughout Japan were anonymously provided and included in the present study.
RESULTS: Details of 332,174 participants (57.3% of the total) with both serum creatinine and dipstick urine test data were analyzed. Mean (SD) age was 63.6 (8.3) years and 40.6% were men. The mean (SD) eGFR was 75.0 (16.2) ml/min/1.73 m(2) and 5.4% had proteinuria. The prevalence of chronic kidney disease (CKD) stage 3, 4, and 5 was 14.2%, 0.2%, and 0.07%, respectively. The prevalence of DM, hypertension, and history of stroke and heart disease was correlated with the combination of eGFR and degree of proteinuria.
CONCLUSION: The findings of the present study indicate that CKD and risk factors for CVD are quite common among middle-aged Japanese. CKD classification based on eGFR and proteinuria may be useful for predicting CVD, mortality rate, and ESRD in the Japanese population.

Entities:  

Mesh:

Year:  2011        PMID: 22057582     DOI: 10.1007/s10157-011-0551-9

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  16 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Global variation in renal replacement therapy for end-stage renal disease.

Authors:  Fergus J Caskey; Anneke Kramer; Robert F Elliott; Vianda S Stel; Adrian Covic; Ana Cusumano; Claudia Geue; Alison M Macleod; Aeilko H Zwinderman; Benedicte Stengel; Kitty J Jager
Journal:  Nephrol Dial Transplant       Date:  2011-01-18       Impact factor: 5.992

3.  An overview of regular dialysis treatment in Japan as of 31 December 2003.

Authors: 
Journal:  Ther Apher Dial       Date:  2005-12       Impact factor: 1.762

4.  Body mass index and the risk of development of end-stage renal disease in a screened cohort.

Authors:  Kunitoshi Iseki; Yoshiharu Ikemiya; Kozen Kinjo; Taku Inoue; Chiho Iseki; Shuichi Takishita
Journal:  Kidney Int       Date:  2004-05       Impact factor: 10.612

5.  Late referral to maintenance dialysis: detrimental consequences.

Authors:  P Jungers; J Zingraff; G Albouze; P Chauveau; B Page; T Hannedouche; N K Man
Journal:  Nephrol Dial Transplant       Date:  1993       Impact factor: 5.992

6.  Differences in stroke subtypes between black and white patients with stroke: the South London Ethnicity and Stroke Study.

Authors:  Hugh S Markus; Usman Khan; Jonathan Birns; Andrew Evans; Lalit Kalra; Anthony G Rudd; Charles D A Wolfe; Paula Jerrard-Dunne
Journal:  Circulation       Date:  2007-10-22       Impact factor: 29.690

7.  Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study.

Authors:  Enyu Imai; Masaru Horio; Kunihiro Yamagata; Kunitoshi Iseki; Shigeko Hara; Nobuyuki Ura; Yutaka Kiyohara; Hirofumi Makino; Akira Hishida; Seiichi Matsuo
Journal:  Hypertens Res       Date:  2008-03       Impact factor: 3.872

8.  Proteinuria and the risk of developing end-stage renal disease.

Authors:  Kunitoshi Iseki; Yoshiharu Ikemiya; Chiho Iseki; Shuichi Takishita
Journal:  Kidney Int       Date:  2003-04       Impact factor: 10.612

9.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

10.  Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study.

Authors:  Koon-Hou Mak; Deepak L Bhatt; Mingyuan Shao; Graeme J Hankey; J Donald Easton; Keith A A Fox; Eric J Topol
Journal:  Am Heart J       Date:  2008-11-06       Impact factor: 4.749

View more
  35 in total

Review 1.  Epidemiology of dyslipidemia in chronic kidney disease.

Authors:  Kunitoshi Iseki
Journal:  Clin Exp Nephrol       Date:  2014-01-11       Impact factor: 2.801

2.  Evidence for prevention of renal dysfunction associated with primary myelofibrosis by cytoreductive therapy.

Authors:  Yasutaka Fukuda; Marito Araki; Kouji Yamamoto; Soji Morishita; Tadaaki Inano; Kyohei Misawa; Tomonori Ochiai; Yoko Edahiro; Misa Imai; Hajime Yasuda; Akihiko Gotoh; Akimichi Ohsaka; Norio Komatsu
Journal:  Haematologica       Date:  2019-04-04       Impact factor: 9.941

3.  Comparison of predictive value for first cardiovascular event between Japanese GFR equation and coefficient-modified CKD-EPI equation.

Authors:  Hiroyuki Terawaki; Masaaki Nakayama; Koichi Asahi; Takeyasu Kakamu; Takehito Hayakawa; Kunitoshi Iseki; Kenjiro Kimura; Toshiki Moriyama; Kunihiro Yamagata; Ichiei Narita; Shouichi Fujimoto; Kazuhiko Tsuruya; Tsuneo Konta; Masahide Kondo; Issei Kurahashi; Yasuo Ohashi; Tetsuhito Fukushima; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2014-07-26       Impact factor: 2.801

4.  A prospective cohort study of insomnia and chronic kidney disease in Japanese workers.

Authors:  Sachiko Sasaki; Eiji Yoshioka; Yasuaki Saijo; Akira Bannai; Toshiko Kita; Akiko Tamakoshi; Reiko Kishi
Journal:  Sleep Breath       Date:  2017-05-22       Impact factor: 2.816

5.  Classification of human immunodeficiency virus-infected patients with chronic kidney disease using a combination of proteinuria and estimated glomerular filtration rate.

Authors:  Naoki Yanagisawa; Takashi Muramatsu; Yasuyuki Yamamoto; Ken Tsuchiya; Kosaku Nitta; Atsushi Ajisawa; Katsuyuki Fukutake; Minoru Ando
Journal:  Clin Exp Nephrol       Date:  2013-08-17       Impact factor: 2.801

6.  Significance of estimated glomerular filtration rate in predicting brain or heart attacks in obese and non-obese populations.

Authors:  Yuji Sato; Shouichi Fujimoto; Tsuneo Konta; Kunitoshi Iseki; Toshiki Moriyama; Kunihiro Yamagata; Kazuhiko Tsuruya; Kenjiro Kimura; Ichiei Narita; Masahide Kondo; Koichi Asahi; Issei Kurahashi; Yasuo Ohashi; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2014-11-30       Impact factor: 2.801

7.  A nationwide prospective cohort study of patients with advanced chronic kidney disease in Japan: The Reach-J CKD cohort study.

Authors:  Junichi Hoshino; Kei Nagai; Hirayasu Kai; Chie Saito; Yukiko Ito; Koichi Asahi; Masahide Kondo; Kunitoshi Iseki; Chiho Iseki; Hirokazu Okada; Naoki Kashihara; Ichiei Narita; Takashi Wada; Christian Combe; Ronald L Pisoni; Bruce M Robinson; Kunihiro Yamagata
Journal:  Clin Exp Nephrol       Date:  2017-07-24       Impact factor: 2.801

8.  Influence of chronic kidney disease on hospitalization, chronic dialysis, and mortality in Japanese men: a longitudinal analysis.

Authors:  Kunihito Nishikawa; Ken Takahashi; Ryoji Yamada; Tsuyoshi Kinaga; Matsumoto Masato; Masayuki Yamamoto
Journal:  Clin Exp Nephrol       Date:  2016-06-23       Impact factor: 2.801

9.  An association between serum γ-glutamyltransferase and proteinuria in drinkers and non-drinkers: a Japanese nationwide cross-sectional survey.

Authors:  Toshihiro Ishigami; Ryohei Yamamoto; Yasuyuki Nagasawa; Yoshitaka Isaka; Hiromi Rakugi; Kunitoshi Iseki; Kunihiro Yamagata; Kazuhiko Tsuruya; Hideaki Yoshida; Shouichi Fujimoto; Koichi Asahi; Issei Kurahashi; Yasuo Ohashi; Toshiki Moriyama; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2014-02-04       Impact factor: 2.801

10.  Glucosuria and all-cause mortality among general screening participants.

Authors:  Kunitoshi Iseki; Tsuneo Konta; Koichi Asahi; Kunihiro Yamagata; Shouichi Fujimoto; Kazuhiko Tsuruya; Ichiei Narita; Masato Kasahara; Yugo Shibagaki; Toshiki Moriyama; Masahide Kondo; Chiho Iseki; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2018-01-12       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.